In the last two weeks, we discussed the use of consumer data and how the FTC is using its power to respond to data privacy concerns. While there are stakeholders who are taking action in response, we wanted to explore a key question: what happens when the concerns raised are left unchecked? Following the 2022 Dobbs v. Jackson decision that overturned Roe v. Wade, we seem to have a test case.

In part three of Radio Advisory’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold and John League to discuss how the Dobbs decision impacts conversations around data privacy and how healthcare leaders should be thinking about protecting patient reproductive data.

Links:

Learn more about Advisory Board On-Demand Courses

In the last episode, we discussed how different industry stakeholders are taking advantage and navigating the challenges of the use of consumer data in healthcare. While the industry wrestles with some concerns about data privacy, the question remains: who is working to protect the data of consumers and patients?

In part two of Advisory Board’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold, Sara Zargham, and Paul Trigonoplos to discuss one stakeholder that is making moves to protect data privacy: the FTC. In the conversation, they explore recent regulatory actions taken by the FTC and what this means for the industry.

Links:

Check out this recent Advisory Board blog post about how to address 5 common challenges seniors face in cancer care

For years, consumers have felt the effects of the increased use of their data. From receiving targeted advertisements to personalized recommendations online, it is no secret that giants in various industries are taking advantage of complex consumer data. But how does this look in the healthcare space?

In part one of a new three-part series on consumer data, host Rachel Woods invites Advisory Board experts Solomon Banjo and Ty Aderhold to discuss how various industry players are taking advantage and navigating the challenges of the use of consumer data in healthcare. In the conversation, they explore exactly what kind of information is being used, what this means for various stakeholders, and how the rising use of consumer health data is poised to radically change the industry.

Links:

Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

For years Advisory Board has been researching how technology and macro-economic forces are shaping clinical decision-making, and recent advances in large language models and AI have the potential to make an impact like we’ve never seen before. In this episode, guest host and Advisory Board life sciences expert Soloman Banjo invites Advisory Board expert Amanda Okaka and Optum’s Senior Vice President of Clinical Innovation Dr. Kevin Larson to discuss the technologies that will change clinical decision-making in the next decade, its implications, and what organizations should be thinking about as they integrate them into clinical workflows.

Links:

Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

Links:

Learn more about Advisory Board On-Demand Courses

Last week we discussed the current state of employer-sponsored insurance and the affordability challenges that the employers are facing. This week, we'll be taking a look at one possible solution for employers: value-based care.

In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care experts Daniel Kuzmanovich and Sophia Hurr to discuss the opportunity that value-based care presents for employers to reduce the costs of care while increasing the quality of care their employees receive. Throughout the conversation, they explore what kinds of employers are best positioned to pursue value-based care, and the different paths to get there.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

While always facing a dynamic landscape, one of the biggest issues today in the employer-sponsored insurance market is affordability. As healthcare costs continue to rise, employers are getting increasingly nervous about their ability to pay for employees’ health insurance, especially in a time of heightened worker shortages.

In this episode, guest host and Advisory Board Vice President and spokesperson Aaron Mauck discusses employer market affordability with Advisory Board health plan experts Sally Kim and Max Hakanson. Throughout the conversation, they explore the context of the problem, root causes, and what the future may look like for employer-sponsored insurance.

Links:

Learn more about Advisory Board On-Demand Courses

Episode 138 was originally released on October 25, 2022.

This week, we're bringing you an encore of our episode with Tom Lawry, the former national director for AI at Microsoft about building ethical AI systems. Not only did this episode recently receive accolades from this year's Communicator Awards – including best healthcare and pharma episode and best business episode – but this conversation is just as, if not more relevant as it was when we recorded it in the Fall of 2022.

While we have a lot to learn about these new technologies, it is clear that AI is top of mind for digital health leaders in 2023. However, revelations about equity issues and bias in artificial intelligence are increasingly giving cause for concern. In this encore of Episode 138, Rachel (Rae) Woods invites Microsoft's former Director for Artificial Intelligence Tom Lawry to discuss how bias creeps into AI and how leaders can respond to make intelligent systems more equitable.

Tom Lawry is the author of Hacking Healthcare, which details lessons learned from AI's role during global pandemic and how to apply this knowledge to healthcare’s other big challenges – including inequity.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

Hospitals and health systems across the globe are looking towards environmental sustainability. However, in a tumultuous economic environment, it can be challenging to balance sustainability efforts with bottom-line necessities while operating under tight margins.

In this episode, guest host and Advisory Board's environmental sustainability expert Miles Cottier invites Bob Biggio, Senior Vice President of Facilities & Support Services at Boston Medical Center, to discuss long-term green financing strategies. Throughout the discussion, they explore Boston Medical Center's medical campus redesign, issuing of "Green Bonds," and their efforts balance sustainability with efficiency and cost-savings.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

Vertical integration and consolidation are significantly altering the healthcare landscape. From health plans to retailers to incumbent health systems, consolidation is reshaping conventional norms in the industry.

In this episode, host Rachel (Rae) Woods speaks with Advisory Board experts Paul Trigonoplos and Eliza Dailey about the reasons for and reactions to the recent explosion in consolidation across the industry. Throughout the discussion, they explore how different stakeholders are responding, and where the future is heading for diversification and integration.

Links:

Learn more about the Advisory Board Fellowship (advisory.com/fellowship)